Target intelligence / Profile preview

Host intestinal epithelial glycoconjugates

Molecular classification
Glycoconjugate, Glycoprotein, Glycolipid, Receptor
01

Overview

Host intestinal epithelial glycoconjugates are a heterogeneous group of carbohydrate-containing molecules, including glycoproteins and glycolipids, expressed on the apical surface of human enterocytes (Sjöberg et al., 1988, PubMed: 2831155). These molecules function as essential receptors for the Colonization Factor Antigen II (CFA/II) fimbriae of Enterotoxigenic Escherichia coli (ETEC), a leading cause of traveler's diarrhea and childhood mortality in developing nations (Wennerås et al., 1990, PubMed: 2185310). The CFA/II complex, comprising the CS1, CS2, and CS3 adhesins, specifically recognizes and binds to terminal sugar moieties such as sialic acid (N-acetylneuraminic acid) and potentially sulfated glycans on the host cell membrane (Madhun et al., 2005, PubMed: 15659434). This high-affinity binding facilitates bacterial colonization and the subsequent delivery of heat-labile (LT) and heat-stable (ST) toxins into the host cells (Fleckenstein et al., 2010, PubMed: 20339537). Because this adhesion step is a prerequisite for infection, these glycoconjugates are significant targets for the development of anti-adhesive therapies, including decoy oligosaccharides and glycomimetic drugs (Shoaf-Sweeney & Hutkins, 2009, PubMed: 18703114). Research into these targets aims to provide non-antibiotic alternatives for preventing ETEC-mediated enteric diseases by blocking the initial attachment phase of the pathogen.

Other names
ETEC CFA/II receptorsIntestinal cell surface glycansSialylated glycoconjugatesCS1/CS2/CS3 receptors
02

Mechanism of action

Competitive inhibition of bacterial fimbrial adhesion to host cell surfaces

03

Biological functions

Cell adhesionCell-cell recognitionMucosal barrier maintenanceHost-microbe interaction
04

Disease associations

InfectionTraveler's diarrheaSecretory diarrhea
05

Safety considerations

Potential disruption of normal host-microbe interactionsInterference with endogenous glycan-mediated signalingImpact on intestinal mucosal integrityAlteration of the commensal microbiome
06

Interacting drugs

Sialyl-lactose

3 more in the full profile.

07

Biomarkers

Sialic acid expression levelsLewis blood group antigen statusSulfated glycan density

Beyond the preview

Go deeper on Host intestinal epithelial glycoconjugates.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal epithelial glycoconjugates.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call